Where will tomorrow’s workforce come from? PART 4: Who are tomorrow’s cell and gene therapy workers?

PART 4: Who are tomorrow’s cell and gene therapy workers? Welcome to a 4-part series exploring a question that the entire cell and gene therapy community is struggling with at the moment: “Where will tomorrow’s workforce come from?” The cell and gene therapy field has been advancing at a breakneck speed for the best part of a decade now, fuelled by long-awaited clinical successes, commercial breakthroughs, and a related startling increase in activity from both investors and big pharma. But wi...